Echocardiographic parameters to identify sickle cell patients with cardio-pathology

Simbo Chiadika1, Mary Lim-Fung1, Fiorella Llanos-Chea2

  • 1Division of Cardiology, Department of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA.

Insights

Sickle cell disease (SCD) significantly impacts heart function, with many patients showing abnormal cardiac parameters. Echocardiography can identify these abnormalities, aiding in risk assessment for better patient outcomes.

Area of Science:

  • Cardiology
  • Hematology
  • Medical Imaging

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder causing chronic hemolytic anemia.
  • Anemia in SCD leads to vasculopathies, including pulmonary hypertension and cardiac dysfunction.
  • These cardiac abnormalities increase morbidity and mortality in SCD patients.

Purpose of the Study:

  • To assess the prevalence of echocardiographic parameters in patients with SCD.
  • To identify specific cardiac abnormalities associated with SCD.
  • To evaluate echocardiographic findings as potential indicators of cardiopulmonary risk in SCD.

Main Methods:

  • Retrospective analysis of 91 SCD patients (53% male, median age 30).
  • Measurement of laboratory and echocardiographic parameters, including left ventricular (LV) dimensions, ejection fraction (LVEF), myocardial performance index (MPI), mass index (MI), and left atrial volume index (LAVI).
  • Assessment of right heart dimensions, tricuspid regurgitation velocity (TRV), and tricuspid annular plane systolic excursion (TAPSE).

Main Results:

  • A high prevalence of left heart abnormalities was observed: 78% had abnormal LV MPI, 38% decreased LVEF, 24% increased LVMI, and 47% increased LAVI.
  • Right heart abnormalities were also common: 59% had increased pulmonary systolic pressure (PASP), 38% increased TRV, and 39% abnormal TAPSE.
  • Increased LVMI and LAVI were significantly associated with hemoglobin levels ≤8 g/dL.

Conclusions:

  • SCD is associated with a high prevalence of left and right heart abnormalities, including abnormal LV MPI, LVMI, diastolic function, LAVI, and PASP.
  • Echocardiographic parameters such as LV MPI and TAPSE are frequently abnormal in SCD patients.
  • These echocardiographic findings represent accessible prognostic tools for identifying cardiopulmonary risk in the SCD population.
Abstract

Related Concept Videos

Wave Parameters01:10

Wave Parameters

The simplest mechanical waves are associated with simple harmonic motion and repeat themselves for several cycles. These simple harmonic waves can be modeled using a combination of sine and cosine functions. Consider a simplified surface water wave that moves across the water's surface. Unlike complex ocean waves, in surface water waves, water moves vertically, oscillating up and down, whereas the disturbance of the wave moves horizontally through the medium. If a seagull is floating on the...
9.4K
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
5.2K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
181
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
464
Identifying Statistically Significant Differences: The F-Test01:14

Identifying Statistically Significant Differences: The F-Test

The F-test is used to compare two sample variances to each other or compare the sample variance to the population variance. It is used to decide whether an indeterminate error can explain the difference in their values. The underlying assumptions that allow the use of the F-test include the data set or sets are normally distributed, and the data sets are independent of each other. The test statistic F is calculated by dividing one variance by another. In other words, the square of one standard...
3.9K
Factors Influencing Drug Absorption: Anatomical Parameters01:23

Factors Influencing Drug Absorption: Anatomical Parameters

Drug absorption involves the movement of drugs from the point of administration into the systemic circulation. Initially, Gastrointestinal (GI) motility propels the drug through the digestive tract and into the stomach. However, the stomach's high acidity and limited surface area restrict its role in drug absorption for most drugs. The drug then moves from the stomach to the small intestine via gastric emptying, which can be slowed by various factors, including interactions with other...
644